The efficacy and safety of anti-EGFR target agents in patients with potentially resectable metastatic colorectal cancer: a meta-analysis of randomized controlled trials

BACKGROUND: Adding anti-epidermal growth factor receptor (anti-EGFR) target agents to conversion therapy may improve the resection rates and survival of patients with potentially resectable metastatic colorectal cancer (mCRC). This study aims to analyze the efficacy and safety of additional anti-EGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Li, Xiangyuan, Huang, Tongmin, Wang, Dongying, He, Yujing, Wei, Mengfei, Chen, Yujie, Zheng, Matao, Shi, Yetan, Zhang, Jianjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601219/
https://www.ncbi.nlm.nih.gov/pubmed/37880688
http://dx.doi.org/10.1186/s12957-023-03222-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601219/
https://www.ncbi.nlm.nih.gov/pubmed/37880688
http://dx.doi.org/10.1186/s12957-023-03222-3

Ejemplares similares